Compare INLX & HBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | INLX | HBIO |
|---|---|---|
| Founded | 1996 | 1901 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Laboratory Analytical Instruments |
| Sector | Technology | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 40.8M | 33.8M |
| IPO Year | N/A | 2000 |
| Metric | INLX | HBIO |
|---|---|---|
| Price | $8.25 | $0.70 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $2.50 |
| AVG Volume (30 Days) | 2.6K | ★ 1.0M |
| Earning Date | 11-12-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $16,539,674.00 | ★ $87,371,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $15.82 | $7.22 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $8.37 | $0.28 |
| 52 Week High | $15.72 | $2.36 |
| Indicator | INLX | HBIO |
|---|---|---|
| Relative Strength Index (RSI) | 31.87 | 53.48 |
| Support Level | $8.40 | $0.71 |
| Resistance Level | $8.53 | $0.78 |
| Average True Range (ATR) | 0.12 | 0.07 |
| MACD | 0.05 | -0.01 |
| Stochastic Oscillator | 10.48 | 34.72 |
Intellinetics Inc is a document service and solutions software company serving both the small-to-medium business and governmental sectors. The company's digital transformation products and services are provided through two reporting segments: Document Management and Document Conversion. The Document Management segment consists of solutions involving software platforms, which allow customers to capture and manage all documents across operations such as scanned hard-copy documents and all digital documents including those from Microsoft Office 365, digital images, audio, video, and emails. The company's Document Conversion offerings aid clients as a part of their overall document to convert documents from one medium to another. Majority of revenue is from Document Conversion Segment.
Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, pharmaceutical and therapy discovery, bioproduction, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life sciences and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, and Panlab. The majority of its revenue comes from the United States.